Home » Diseases » Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome: Disease Bioinformatics
Submit your image related to Diseases to be featured!
Submit an Image

Get Social

Submit your Twitter account related to Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome to be featured!
Submit an Account

Blogs

 Submit your blog on Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome to be featured!
Submit a Blog

Events

 Submit your event on Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome to be featured!
Submit an Event

Videos

Submit your video on Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome to be featured!
Submit a Video

Charities

Submit your charity on Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome to be featured!
Submit a Charity

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome: Disease Bioinformatics

Research of Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been linked to Transient Ischemic Attack, Malnutrition, Cerebrovascular Accident, Cerebrovascular Disorders, Brain Ischemia. The study of Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome include Localization, Fermentation, Regeneration, Pathogenesis, Transport. These pathways complement our catalog of research reagents for the study of Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome including antibodies and ELISA kits against NOS2, CEACAM5, CEACAM7, PSG2, CASP3.

Top Research Reagents

We have 1852 products for the study of Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome that can be applied to Chromatin Immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.

Cholecystokinin Antibody (2753A) [Unconjugated]
MAB11040
CCK was detected in immersion fixed Capan‑2 human pancreatic adenocarcinoma cell line (positive staining) and Daudi human Burkitt's lymphoma cell line (negative staining) using Rabbit Anti-Human CCK Monoclonal Antibody (Catalog # MAB11040) at 3 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rabbit IgG Secondary Antibody (red; Catalog # <a class=NoLineLink href=CCK was detected in immersion fixed paraffin-embedded sections of human duodenum using Rabbit Anti-Human CCK Monoclonal Antibody (Catalog # MAB11040) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Rabbit IgG VisUCyte™ HRP Polymer Antibody (<a class=NoLineLink href=

Rabbit Monoclonal
Species Human
Applications IHC, ICC

iNOS Antibody - BSA Free
NB300-605
Western Blot: iNOS Antibody [NB300-605] - Analysis of iNOS was performed by loading 20 ug of RAW264 whole cell lysate untreated (left lane) or stimulated with LPS at 1 ug/mL for 16 hours (right lane) and 10 uL of PageRuler Plus Prestained Protein Ladder onto a 4-20% Tris-Glycine polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane and blocked with 5% Milk in TBST for at least 1 hour. The membrane was probed with an iNOS Rabbit polyclonal antibody at a dilution of 1:1000 overnight at 4C on a rocking platform, washed in TBST, and probed with a Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at a dilution of 1:1000 for 1 hour. Chemiluminescent detection was performed using SuperSignal West Pico.Immunohistochemistry-Paraffin: iNOS Antibody [NB300-605] - Immunohistochemistry was performed on normal deparaffinized human Lung tissue.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, Flow, IB

     3 Reviews

130 Publications
PUM3 Antibody
NBP1-57531
Western Blot: KIAA0020 Antibody [NBP1-57531] - HepG2 cell lysate, Antibody Titration: 1.25ug/mlImmunohistochemistry: KIAA0020 Antibody [NBP1-57531] - Human alveolar cell Cellular data: Epithelial cells of renal tubule Antibody Concentration: 4.0-8.0 ug/ml Magnification: 400X.

Rabbit Polyclonal
Species Human
Applications WB, IHC, IHC-P

BRAP Antibody
NBP1-91705
Western Blot: BRAP Antibody [NBP1-91705] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).Immunocytochemistry/Immunofluorescence: BRAP Antibody [NBP1-91705] - Immunofluorescent staining of human cell line U-2 OS shows localization to nuclear membrane & cytosol.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, ICC/IF, IHC

COX-2 Antibody
NB100-689
Immunohistochemistry-Paraffin: COX-2 Antibody [NB100-689] - Formalin fixed paraffin embedded colon carcinoma stained with COX-2 antibody (NB100-689).Simple Western: COX-2 Antibody [NB100-689] - Simple Western lane view shows a specific band for COX2 in 1.0 mg/ml of Rat Brain at an antibody concentration of 1:100. This experiment was performed under reducing conditions using the 12-230 kDa separation system. Image provided through customer review.

Rabbit Polyclonal
Species Human, Rat
Applications WB, Simple Western, IHC

     1 Review

36 Publications
Neprilysin-2/MMEL1 Antibody
AF2340

Goat Polyclonal
Species Human
Applications WB, Flow, IP

     1 Review

1 Publication
Plexin B1 Antibody [Unconjugated]
AF3749

Goat Polyclonal
Species Human
Applications WB, IHC

6 Publications
Exostosin-like 3/EXTL3 Antibody
AF2635

Goat Polyclonal
Species Human
Applications WB

4 Publications
Caspase-3 Antibody [Unconjugated] - Active
AF835
Caspase‑3 was detected in immersion fixed anti-FAS treated Jurkat human acute T cell leukemia cell line using 0.3 µg/mL Human/Mouse Active Caspase‑3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF835) for 3 hours at room temperature. Cells were stained (red) and counterstained (green). View our protocol for <a class=Caspase-3 was detected in immersion fixed Jurkat human acute T cell leukemia cell line stimulated with staurosporin using Human/Mouse Active Caspase-3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF835) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rabbit IgG Secondary Antibody (yellow; Catalog # <a class=

Rabbit Polyclonal
Species Human, Mouse
Applications IHC, ICC

     7 Reviews

384 Publications
CS Citrate Synthase Antibody (1761)
NBP2-43648
Western Blot: CS Citrate Synthase Antibody (1761) [NBP2-43648] - Non-transfected (Negative) and transfected (Positive) 293T whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Citrate synthetase antibody diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.Immunocytochemistry/Immunofluorescence: CS Citrate Synthase Antibody (1761) [NBP2-43648] - HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Citrate synthetase protein stained by Citrate synthetase antibody [1761] diluted at 1:200. Red: phalloidin, a cytoskeleton marker, diluted at 1:50. Blue: Hoechst 33342 staining.

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, ICC/IF, IHC

     1 Review

1 Publication
ISYNA1 Antibody
NBP2-47415
Western Blot: ISYNA1 Antibody [NBP2-47415] - Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human cell line HEK 293Immunocytochemistry/Immunofluorescence: ISYNA1 Antibody [NBP2-47415] - Immunofluorescent staining of human cell line HEK 293 shows localization to nucleus & cytosol.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC

CEACAM7 Antibody (962720) [Unconjugated]
MAB44782
HEK293 human embryonic kidney cell line transfected with human CEACAM-7 and eGFP was stained with either (A) Mouse Anti-Human CEACAM-7 Monoclonal Antibody (Catalog # MAB44782) or (B) Mouse IgG1 Isotype Control(Catalog # <a class= CEACAM‑7 was detected in immersion fixed paraffin-embedded sections of human colon cancer tissue using Mouse Anti-Human CEACAM‑7 Monoclonal Antibody (Catalog # MAB44782) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # <a class=

Mouse Monoclonal
Species Human
Applications ELISA, Flow, IHC

1 Publication
Tyrosinase Antibody (JA52-11)
NBP2-67232
Western Blot: Tyrosinase Antibody (JA52-11) [NBP2-67232] - Western blot analysis of Tyrosinase on B16F1 cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature.Immunocytochemistry/Immunofluorescence: Tyrosinase Antibody (JA52-11) [NBP2-67232] - Staining Tyrosinase in B16F1 cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.

Rabbit Monoclonal
Species Human, Mouse
Applications WB, ICC/IF, IHC

CEACAM5/CD66e Antibody (CEA31) - Azide and BSA Free
NBP2-34594
Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) - Azide and BSA Free [NBP2-34594] - Analysis of CEACAM5/CD66e antibody (CEA31) on Human Colon Carcinoma. Incubation: 1 ug/mL for 30 minutes at room temperature.Image from verified customer review.Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) - Azide and BSA Free [NBP2-34594] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).

Mouse Monoclonal
Species Human, Monkey
Applications Flow, ICC/IF, IHC

     2 Reviews


Related Genes

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been researched against:

Related Pathways

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been linked to:

Related Diseases

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been studied in relation to diseases such as:

Related PTMs

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome has been studied in relation to posttranslational modifications (PTMs) including:

Alternate Names

Reversible Ischemic Neurologic Deficit (r.i.n.d.) Syndrome is also known as Reversible Ischaemic Neurological Deficit, Reversible Ischemic Neurologic Deficit, Reversible Ischemic Neurological Deficit, Rind.